Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial - Dimitroulopoulos, D; Xinopoulos, D; Tsamakidis, K (World J Gastroenterol, 2007)
et al.